Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pen-Tsao Chemical Industry
Wan Chai, Hong Kong, Chinapentsao.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Pen-Tsao Chemical Industry is a specialty pharmaceutical and chemical manufacturing company that focuses on the development of niche Active Pharmaceutical Ingredients (APIs) and Oral Solid Dosage (OSD) formulations. The company is notably involved in the clinical development of Tauroursodeoxycholic acid (TUDCA) for neurodegenerative conditions like ALS and provides a wide range of generic APIs and intermediates to the global market.
- Therapeutic areas
- CardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
TUDCA-ALS Consortium
Beyond the preview
Go deeper on Pen-Tsao Chemical Industry.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pen-Tsao Chemical Industry.